Your browser doesn't support javascript.
loading
Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study.
Galloway-Peña, Jessica R; Peterson, Christine B; Malik, Farida; Sahasrabhojane, Pranoti V; Shah, Dimpy P; Brumlow, Chelcy E; Carlin, Lily G; Chemaly, Roy F; Im, Jin Seon; Rondon, Gabriela; Felix, Edd; Veillon, Lucas; Lorenzi, Philip L; Alousi, Amin M; Jenq, Robert R; Kontoyiannis, Dimitrios P; Shpall, Elizabeth J; Shelburne, Samuel A; Okhuysen, Pablo C.
Afiliación
  • Galloway-Peña JR; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Peterson CB; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston.
  • Malik F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.
  • Sahasrabhojane PV; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Shah DP; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Brumlow CE; Department of Epidemiology and Biostatistics, Long School of Medicine and Mays Cancer Center, University of Texas Health Science Center at San Antonio.
  • Carlin LG; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Chemaly RF; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Im JS; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Rondon G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston.
  • Felix E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston.
  • Veillon L; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston.
  • Lorenzi PL; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston.
  • Alousi AM; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston.
  • Jenq RR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston.
  • Kontoyiannis DP; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston.
  • Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston.
  • Shelburne SA; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Okhuysen PC; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.
Open Forum Infect Dis ; 6(5): ofz173, 2019 May.
Article en En | MEDLINE | ID: mdl-31065565
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2019 Tipo del documento: Article